
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[GMAB] Genmab - Long-Term Investments
Data updated 2023-Sep-23 (Saturday)Note: Detailed Statistics for Long-Term Investments in Balance Sheet for Genmab [NASDAQ:GMAB] with frequency distribution chart that analyze trends & history . Long-Term Investments include real estate, securities etc. that the Company plans to hold for longer than a year. View Balance Sheet for broader context
Share
Quarterly Long-Term Investments values for Genmab are rounded to enhance readability
2023-Jun | 2023-Mar | 2022-Dec | 2022-Sep | 2022-Jun | 2022-Mar | |
---|---|---|---|---|---|---|
Long-Term Investments | 183 M | 140 M | 133 M | 155 M | 201 M | 239 M |
Sequential Quarter Growth | +30.7% | +5.3% | -14.2% | -22.9% | -15.9% | -35.6% |
Quarter-on Quarter Growth | -9.0% | -41.4% | -64.2% | -73.6% | -73.3% | -73.6% |
Annual Long-Term Investments values for Genmab are rounded to enhance readability
2022-Dec | 2021-Dec | 2020-Dec | 2019-Dec | 2018-Dec | 2017-Dec | |
---|---|---|---|---|---|---|
Long-Term Investments | 133 M | 371 M | 1.08 B | 149 M | - | - |
Year-on-Year Growth | -64.2% | -65.7% | +625.5% | +Inf% | NaN% | |
2-yr CAGR | -64.9% | +57.8% | ||||
3-yr CAGR | -3.7% | |||||
4-yr CAGR | ||||||
5-yr CAGR |
Frequency distribution of quarterly Long-Term Investments values from 2016-Dec-31 grouped into buckets. Latest Long-Term Investments value is 183 Million as of 2023-Jun-30
Subsequent stock performance post earnings date till next announcement for Genmab mapped with quarterly Long-Term Investments values reported at that time. Most recent value denoted with star
Select frequency and calculation type for Long-Term Investments above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Genmab with subsequent post-earnings performance given Long-Term Investments values. Analysis uses quarterly data and subsequent relative performance benchmarked to S&P 500 index. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (relative perf.) | Outperform (relative perf.) | |
---|---|---|
Long-Term Investments - Low | 17% | 83% |
Long-Term Investments - Medium | 60% | 40% |
Long-Term Investments - High | 80% | 20% |
Long-Term Investments (Sequential growth %) - Low | 67% | 33% |
Long-Term Investments (Sequential growth %) - Medium | 0% | 100% |
Long-Term Investments (Sequential growth %) - High | 80% | 20% |
Long-Term Investments (QoQ growth %) - Low | 60% | 40% |
Long-Term Investments (QoQ growth %) - Medium | 40% | 60% |
Long-Term Investments (QoQ growth %) - High | 60% | 40% |
Related to Genmab
Information for Genmab
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Jul-03 on Google
SEC Reports : Quarterly reports around 2025-Jul-03 on SEC Edgar
Compare Genmab with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Genmab
Industry : Biotechnology industry performance which includes Genmab